With vaccine revenue crumbling and layoffs in full swing, is Moderna’s slimmed-down strategy a smart move or a red flag for ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

Termination of contracts and “de-scoping” of mRNA-related work in existing contracts, along with other changes, will affect ...

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...

Q2 2025 Earnings Call Transcript August 1, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-2.13, ...

RNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of ...

The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...